Showing results (201-210 of 261) with videos related to

Sort By:
Pageof 27
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|January 14, 2026
Peripheral scleral lens modifications and tear exchangeAsif Iqbal, Damien Fisher, David Alonso-Caneiro, et al.
European Journal of Immunology|March 12, 2025
Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to Escherichia coli and Klebsiella pneumoniae PhagesHuu Thanh Le, Carola Venturini, Alicia Fajardo Lubian, et al.
American Journal of Ophthalmology|November 5, 2013
Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2bJenna Besley, Juanita Pappalardo, Graham A Lee, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|November 27, 2025
Scleral lens landing zone toricity and tear exchangeAsif Iqbal, Damien Fisher, David Alonso-Caneiro, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|March 13, 2025
Regional variations in corneal oedema during open-eye fenestrated scleral lens wearAsif Iqbal, Damien Fisher, David Alonso-Caneiro, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|August 20, 2024
The central and peripheral corneal response to short-term hypoxiaAsif Iqbal, Damien Fisher, David Alonso-Caneiro, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|May 6, 2026
Tear Dynamics During Fenestrated Scleral Lens Wear: A Pilot StudyDamien Fisher, Asif Iqbal, David Alonso-Caneiro, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association|July 18, 2026
Scleral lens peripheral modifications and regional variations in corneal oedemaAsif Iqbal, Damien Fisher, David Alonso-Caneiro, et al.
The Journal of General Virology|July 24, 2014
Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agentsMahsa Shahidi, Enoch S E Tay, Scott A Read, et al.
Plos One|August 28, 2015
Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon ResponseScott A Read, Enoch S Tay, Mahsa Shahidi, et al.
Pageof 27